Synapse - GDMT, Medicine

Results (1915)

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development

Meeting Abstract

Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer

Meeting Abstract

Landen, C. N.; Buckanovich, R. J.; Sill, M.; Mannel, R. S.; Walker, J. L.; Disilvestro, P.; Mathews, C. A.; Mutch, D. G.; Hernandez, M.; Martin, L. P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Phase 1 study of SGN-ALPV, a novel, investigational vedotin antibody-drug conjugate directed to ALPP/ALPPL2 in advanced solid tumors (SGNALPV-001, trial in progress)

Meeting Abstract

Lakhani, N. J.; Friedman, C. F.; Perez, C. A.; Wehr, A.; McGoldrick, S. M.; LoRusso, P.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)

Meeting Abstract

Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)

Meeting Abstract

Harrold, E.; Solter, M.; Walch, H. S.; Chatila, W. K.; Keane, F.; Lumish, M. A.; Yaeger, R.; Weiss, J. A.; Palmaira, R. L.; Krishnan, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade

Meeting Abstract

Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)

Meeting Abstract

Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)

Meeting Abstract

Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Efficacy and safety of rucaparib maintenance treatment in patients from ARIEL3 with platinum-sensitive, recurrent ovarian carcinoma not associated with homologous recombination deficiency

Meeting Abstract

Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer

Meeting Abstract

Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save